[HTML][HTML] Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - PloS one, 2017 - journals.plos.org
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered “undruggable” and to develop …
active sites, make it possible to target proteins considered “undruggable” and to develop …
Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - PloS one, 2017 - profiles.wustl.edu
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered aundruggableo and to develop …
active sites, make it possible to target proteins considered aundruggableo and to develop …
[HTML][HTML] Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - PLoS ONE, 2017 - ncbi.nlm.nih.gov
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered “undruggable” and to develop …
active sites, make it possible to target proteins considered “undruggable” and to develop …
Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - PLoS ONE, 2017 - go.gale.com
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered" undruggable" and to develop …
active sites, make it possible to target proteins considered" undruggable" and to develop …
[引用][C] Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - PLoS …, 2017 - ui.adsabs.harvard.edu
Designing small molecules to target cryptic pockets yields both positive and negative allosteric
modulators - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …
modulators - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …
[PDF][PDF] Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - PLoS ONE, 2017 - core.ac.uk
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered “undruggable” and to develop …
active sites, make it possible to target proteins considered “undruggable” and to develop …
[PDF][PDF] Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho… - PLoS …, 2017 - pdfs.semanticscholar.org
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered “undruggable” and to develop …
active sites, make it possible to target proteins considered “undruggable” and to develop …
Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - PloS …, 2017 - pubmed.ncbi.nlm.nih.gov
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered" undruggable" and to develop …
active sites, make it possible to target proteins considered" undruggable" and to develop …
Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators.
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - Plos one, 2017 - europepmc.org
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered “undruggable” and to develop …
active sites, make it possible to target proteins considered “undruggable” and to develop …
[PDF][PDF] Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
KM Hart, KE Moeder, CMW Ho, MI Zimmerman… - 2017 - digitalcommons.wustl.edu
Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or
active sites, make it possible to target proteins considered “undruggable” and to develop …
active sites, make it possible to target proteins considered “undruggable” and to develop …